Firms

Sanford Biosciences LLC

Sanford Biosciences LLC

Sanford Biosciences LLC (SBL) is a private life-sciences investment organization explicitly identified in EnBiotix’s December29,2021 financing announcement as the life-sciences investment arm of T. Denny Sanford. Its verified financing activity includes QurAlis, a precision-medicine developer targeting ALS and genetically related frontotemporal degeneration. This makes it a relevant neuroscience and biotechnology investor, rather than an AI-software operating company or a public grant programme. QurAlis names Sanford Biosciences as an existing-investor participant in its USD42million Series A announced May13,2020 and USD88million Series B announced March9,2023. Those figures are total issuer rounds, not Sanford’s individual investment checks; allocations and fund-vehicle attribution are undisclosed. EnBiotix explicitly names Sanford Biosciences LLC in an actual USD11million convertible-note financing closed and announced December29,2021 alongside Vectura and the Cystic Fibrosis Foundation. Its successor Spexis’s May2022 corporate capital documentation also separately names the LLC as a shareholder; merger shares do not constitute additional fresh investment cash. EnClear Therapies publishes the exact Sanford Biosciences wordmark among its institutional/strategic partners. A current partner listing alone does not establish a specific additional round or amount. Sanford Biosciences LLC is kept distinct from Sanford Applied Biosciences, the Sanford Health wholly owned biotechnology subsidiary that developed antibody-producing bovine technology subsequently acquired by SAB in June2014, as documented in SAB’s SEC filings. Neither Sanford Health nor Sanford Burnham Prebys Medical Discovery Institute is treated as this private LLC’s legal parent or duplicate cash investor. Sanford Laboratories for Innovative Medicines at sanfordlabs.org is a separately described nonprofit research institution; a secondary-directory link is not a legal alias bridge. The primary sources do not establish a rename from the Applied Biosciences company into this investment organization. The only independently verified public principal is historical T. Denny Sanford. A primary beneficiary institution confirms he died July18,2026; he is not represented as a current manager. Current investment employees, decision makers, succession arrangements, precise founding date, registered headquarters and a dedicated official investor website are not verified in accessible primary materials. The stored logo is the original exact issuer-published investor wordmark from EnClear, not the logo of a similarly named hospital or laboratory. No outside LP fund closes, AUM, nonprofit operating budgets or philanthropic gifts are represented as fund capital raised by this LLC. South Dakota’s official entity-search interface supplies no retrievable exact legal detail in this audit; a secondary listing’s inconsistent2015/2017 dates and registered-agent address are not promoted to verified founding or headquarters facts.

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

No team members on record yet.

Co-investing

Amgen Ventures
Dementia Discovery Fund
Dolby Family Ventures
Droia Ventures
INKEF Capital

Investments